Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 29, 2004 04:19 ET | Source: Medivir

Medivir: Cathepsin S Research Programme Designates Candidate Drug (CD)

HUDDINGE, Sweden, March 29, 2004 (PRIMEZONE) -- Medivir and Peptimmune jointly announce today that an orally active, small molecule inhibitor of the protease enzyme Cathepsin S has been selected as a...